{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:28:38Z","timestamp":1754195318789},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2014,11,8]],"date-time":"2014-11-08T00:00:00Z","timestamp":1415404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s11010-014-2263-4","type":"journal-article","created":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T16:28:34Z","timestamp":1415982514000},"page":"69-75","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Circulating levels of apelin, glucagon-like peptide and visfatin in hypercholesterolemic\u2013hyperhomocysteinemic guinea-pigs: their relation with NO metabolism"],"prefix":"10.1007","volume":"400","author":[{"given":"Zeynep","family":"Kusku-Kiraz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Genc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seldag","family":"Bekpinar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Unlucerci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vakur","family":"Olgac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujdat","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Figen","family":"Gurdol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,8]]},"reference":[{"key":"2263_CR1","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/01.ATV.0000080686.39871.54","volume":"23","author":"A Zulli","year":"2003","unstructured":"Zulli A, Widdop RE, Hare DL (2003) High methionine and cholesterol diet abolishes endothelial relaxation. Arterioscler Thromb Vasc Biol 23:1358\u20131363","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2263_CR2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1055\/s-2005-921098","volume":"37","author":"J Boucher","year":"2005","unstructured":"Boucher J, Castan-Laurell I, Daviaud D (2005) Adipokine expression profile in adipocytes of different mouse models of obesity. Horm Metab Res 37:761\u2013776","journal-title":"Horm Metab Res"},{"key":"2263_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.regpep.2003.11.002","volume":"118","author":"MJ Kleinz","year":"2004","unstructured":"Kleinz MJ, Davenport AP (2004) Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regul Pept 118:119\u2013125","journal-title":"Regul Pept"},{"key":"2263_CR4","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","volume":"251","author":"K Tatemoto","year":"1998","unstructured":"Tatemoto K, Hosoya M, Habata Y et al (1998) Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251:471\u2013476","journal-title":"Biochem Biophys Res Commun"},{"key":"2263_CR5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF03165767","volume":"63","author":"C Carpene","year":"2007","unstructured":"Carpene C, Dray C, Attane C et al (2007) Expanding role for the apelin\/APJ system in physiopathology. J Physiol Biochem 63:359\u2013373","journal-title":"J Physiol Biochem"},{"key":"2263_CR6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.regpep.2005.09.032","volume":"133","author":"JP Goetze","year":"2006","unstructured":"Goetze JP, Rehfeld JF, Carlsen J et al (2006) Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept 133:134\u2013138","journal-title":"Regul Pept"},{"key":"2263_CR7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0167-0115(01)00236-1","volume":"99","author":"K Tatemoto","year":"2001","unstructured":"Tatemoto K, Takayama K, Zou MX et al (2001) The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99:87\u201392","journal-title":"Regul Pept"},{"key":"2263_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1758-5996-2-21","volume":"2","author":"P Saddi-Rosa","year":"2010","unstructured":"Saddi-Rosa P, Oliveira CS, Giuffrida FM et al (2010) Visfatin, glucose metabolism and vascular disease: a review of evidence. Diabetol Metab Syndr 2:21","journal-title":"Diabetol Metab Syndr"},{"key":"2263_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1210\/jc.2005-1475","volume":"91","author":"MP Chen","year":"2006","unstructured":"Chen MP, Chung FM, Chang DM (2006) Elevated plasma level of visfatin\/pre-B cell colony-stimulating factor in patients with type 2 diabetes. J Clin Endocrinol Metab 91:295\u2013299","journal-title":"J Clin Endocrinol Metab"},{"key":"2263_CR10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2265.2008.03453.x","volume":"71","author":"SW Liu","year":"2009","unstructured":"Liu SW, Qiao SB, Yuan JS et al (2009) Association of plasma visfatin levels with inflammation, atherosclerosis, and acute coronary syndromes in humans. Clin Endocrinol (Oxf) 71:202\u2013207","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2263_CR11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","volume":"113","author":"ME Doyle","year":"2007","unstructured":"Doyle ME, Egan JM (2007) Mechanisms of action of GLP-1 in the pancreas. Pharmacol Ther 113:546\u2013593","journal-title":"Pharmacol Ther"},{"key":"2263_CR12","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2174\/187152512803530388","volume":"10","author":"T Mita","year":"2012","unstructured":"Mita T, Watada H (2012) Glucagon like peptide-1 and atherosclerosis. Cardiovasc Hematol Agents Med Chem 10:309\u2013318","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"2263_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2840-9-17","volume":"9","author":"M Yamaoka-Tojo","year":"2010","unstructured":"Yamaoka-Tojo M, Tojo T, Takahira N et al (2010) Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease. Cardiovasc Diabetol 9:17","journal-title":"Cardiovasc Diabetol"},{"key":"2263_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1475-2840-12-117","volume":"12","author":"K Piotrowski","year":"2013","unstructured":"Piotrowski K, Becker M, Zugwurst J et al (2013) Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans. Cardiovasc Diabetol 12:117. doi: 10.1186\/1475-2840-12-117","journal-title":"Cardiovasc Diabetol"},{"key":"2263_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1271\/bbb.120722","volume":"77","author":"J Coban","year":"2013","unstructured":"Coban J, Evran B, Ozkan F et al (2013) Effect of blueberry feeding on lipids and oxidative stress in the serum, liver and aorta of guinea pigs fed on a high-cholesterol diet. Biosci Biotechnol Biochem 77:389\u2013391","journal-title":"Biosci Biotechnol Biochem"},{"key":"2263_CR16","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.nut.2008.09.017","volume":"25","author":"S Yalcinkaya","year":"2009","unstructured":"Yalcinkaya S, Unlucerci Y, Giris M et al (2009) Oxidative and nitrosative stress and apoptosis in the liver of rats fed on high methionine diet: protective effect of taurine. Nutrition 25:436\u2013444","journal-title":"Nutrition"},{"key":"2263_CR17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419","journal-title":"Diabetologia"},{"key":"2263_CR18","first-page":"263","volume":"108","author":"T Teerlink","year":"2005","unstructured":"Teerlink T (2005) Determination of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine in biological samples by HPLC. Methods Mol Med 108:263\u2013274","journal-title":"Methods Mol Med"},{"key":"2263_CR19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11745-998-0201-2","volume":"33","author":"K Sugiyama","year":"1998","unstructured":"Sugiyama K, Kumazawa A, Zhou H et al (1998) Dietary methionine level affects linoleic acid metabolism through phosphatidylethanolamine N-methylation in rats. Lipids 33:235\u2013242","journal-title":"Lipids"},{"key":"2263_CR20","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1079\/BJN20061729","volume":"95","author":"F Hirche","year":"2006","unstructured":"Hirche F, Schr\u00f6der A, Knoth B et al (2006) Effect of dietary methionine on plasma and liver cholesterol concentrations in rats and expression of hepatic genes involved in cholesterol metabolism. Br J Nutr 95:879\u2013888","journal-title":"Br J Nutr"},{"key":"2263_CR21","doi-asserted-by":"crossref","first-page":"E1002","DOI":"10.1152\/ajpendo.00518.2004","volume":"288","author":"CW Woo","year":"2005","unstructured":"Woo CW, Siow YL, Pierce GN et al (2005) Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors. Am J Physiol Endocrinol Metab 288:E1002\u2013E1010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2263_CR22","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","volume":"352","author":"GK Hansson","year":"2005","unstructured":"Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685\u20131695","journal-title":"N Engl J Med"},{"key":"2263_CR23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1089-8603(02)00111-8","volume":"7","author":"H Li","year":"2002","unstructured":"Li H, Wallerath T, M\u00fcnzel T et al (2002) Regulation of endothelial type NO synthase expression in pathophysiology and in response to drugs. Nitric Oxide Biol Chem 7:149\u2013164","journal-title":"Nitric Oxide Biol Chem"},{"key":"2263_CR24","first-page":"16","volume":"58","author":"A Szuba","year":"2006","unstructured":"Szuba A, Podg\u00f3rski M (2006) Asymmetric dimethylarginine (ADMA) a novel cardiovascular risk factor\u2014evidence from epidemiological and prospective clinical trials. Pharmacol Rep 58:16\u201320","journal-title":"Pharmacol Rep"},{"key":"2263_CR25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","volume":"60","author":"RH B\u00f6ger","year":"2009","unstructured":"B\u00f6ger RH, Maas R, Schulze F et al (2009) Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality\u2014an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60:481\u2013487","journal-title":"Pharmacol Res"},{"key":"2263_CR26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1590\/1414-431X20132595","volume":"46","author":"MBP Landim","year":"2013","unstructured":"Landim MBP, Dourado PM, Casella-Filho A et al (2013) High plasma concentrations of asymmetric dimethylarginine inhibit ischemic cardioprotection in hypercholesterolemic rats. Braz J Med Biol Res 46:454\u2013459","journal-title":"Braz J Med Biol Res"},{"key":"2263_CR27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0008-6363(02)00617-X","volume":"57","author":"K Sydow","year":"2003","unstructured":"Sydow K, Schwedhelm E, Arakawa N et al (2003) ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of l-arginine and B vitamins. Cardiovasc Res 57:244\u2013252","journal-title":"Cardiovasc Res"},{"key":"2263_CR28","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/ATVBAHA.111.228833","volume":"31","author":"JP Cooke","year":"2011","unstructured":"Cooke JP, Ghebremariam YT (2011) DDAH says NO to ADMA. Arterioscler Thromb Vasc Biol 31:1462\u20131464","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2263_CR29","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1139\/cjpp-2013-0114","volume":"91","author":"S Bekpinar","year":"2013","unstructured":"Bekpinar S, Develi-Is S, Unlucerci Y et al (2013) Modulation of arginine and asymmetric dimethylarginine concentrations in liver and plasma by exogenous hydrogen sulfide in LPS-induced endotoxemia. Can J Physiol Pharmacol 91:1071\u20131075","journal-title":"Can J Physiol Pharmacol"},{"key":"2263_CR30","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","volume":"108","author":"MC St\u00fchlinger","year":"2003","unstructured":"St\u00fchlinger MC, Oka RK, Graf EE et al (2003) Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation 108:933\u2013938","journal-title":"Circulation"},{"key":"2263_CR31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/01.RES.87.1.45","volume":"7","author":"H Jakubowski","year":"2000","unstructured":"Jakubowski H, Zhang L, Bardeguez A et al (2000) Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 7:45\u201351","journal-title":"Circ Res"},{"key":"2263_CR32","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/ja0430200","volume":"127","author":"M Knipp","year":"2005","unstructured":"Knipp M, Braun O, Vas\u00e1k M (2005) Searching for DDAH inhibitors: S-nitroso-l-homocysteine is a chemical lead. J Am Chem Soc 127:2372\u20132373","journal-title":"J Am Chem Soc"},{"key":"2263_CR33","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U F\u00f6rstermann","year":"2012","unstructured":"F\u00f6rstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33:829\u2013837","journal-title":"Eur Heart J"},{"key":"2263_CR34","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/320454a0","volume":"320","author":"RJ Gryglewski","year":"1986","unstructured":"Gryglewski RJ, Palmer RM, Moncada S (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320:454\u2013456","journal-title":"Nature"},{"key":"2263_CR35","doi-asserted-by":"crossref","first-page":"32460","DOI":"10.1074\/jbc.M910433199","volume":"275","author":"CD Reiter","year":"2000","unstructured":"Reiter CD, Teng RJ, Beckman JS (2000) Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite. J Biol Chem 275:32460\u201332466","journal-title":"J Biol Chem"},{"key":"2263_CR36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1055\/s-2007-971067","volume":"115","author":"I Tasci","year":"2007","unstructured":"Tasci I, Dogru T, Naharci I et al (2007) Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes 115:428\u2013432","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"15","key":"2263_CR37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2369-15-18","volume":"16","author":"S Karadag","year":"2014","unstructured":"Karadag S, Ozturk S, Gursu M et al (2014) The relationship between apelin and cardiac parameters in patients on peritoneal dialysis: is there a new cardiac marker? BMC Nephrol 16(15):18. doi: 10.1186\/1471-2369-15-18","journal-title":"BMC Nephrol"},{"key":"2263_CR38","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1253\/circj.CJ-13-1561","volume":"78","author":"J Oyama","year":"2014","unstructured":"Oyama J, Node K (2014) Incretin therapy and heart failure. Circ J 78:819\u2013824","journal-title":"Circ J"},{"key":"2263_CR39","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11892-014-0483-3","volume":"14","author":"A Avogaro","year":"2014","unstructured":"Avogaro A, Vigili de Kreutzenberg S, Fadini GP (2014) Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. Curr Diabetes Rep 14:483. doi: 10.1007\/s11892-014-0483-3","journal-title":"Curr Diabetes Rep"},{"key":"2263_CR40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.112.091215","volume":"127","author":"MH Noyan-Ashraf","year":"2013","unstructured":"Noyan-Ashraf MH, Shikatani EA, Schuiki I et al (2013) A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity. Circulation 127:74\u201385","journal-title":"Circulation"},{"key":"2263_CR41","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/aps.2011.149","volume":"33","author":"L Ding","year":"2012","unstructured":"Ding L, Zhang G (2012) Glucagon-like peptide-1 activates endothelial nitric oxide synthase in human umbilical vein endothelial cells. Acta Pharmacol Sin 33:75\u201381","journal-title":"Acta Pharmacol Sin"},{"key":"2263_CR42","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2011.12.039","volume":"221","author":"A Shiraki","year":"2012","unstructured":"Shiraki A, Oyama J, Komoda H et al (2012) The glucagon-like peptide 1 analog liraglutide reduces TNF-\u03b1-induced oxidative stress and inflammation in endothelial cells. Atherosclerosis 221:375\u2013382","journal-title":"Atherosclerosis"},{"key":"2263_CR43","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2010.09.012","volume":"412","author":"NP Kadoglou","year":"2011","unstructured":"Kadoglou NP, Gkontopoulos A, Kapelouzou A et al (2011) Serum levels of vaspin and visfatin in patients with coronary artery disease\u2014Kozani study. Clin Chim Acta 412:48\u201352","journal-title":"Clin Chim Acta"},{"key":"2263_CR44","doi-asserted-by":"crossref","first-page":"e27299","DOI":"10.1371\/journal.pone.0027299","volume":"6","author":"S Vallejo","year":"2011","unstructured":"Vallejo S, Romacho T, Angulo J et al (2011) Visfatin impairs endothelium-dependent relaxation in rat and human mesenteric microvessels through nicotinamide phosphoribosyltransferase activity. PLoS ONE 6:e27299","journal-title":"PLoS ONE"},{"key":"2263_CR45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2169\/internalmedicine.51.6609","volume":"51","author":"F Gunes","year":"2012","unstructured":"Gunes F, Akbal E, Cakir E et al (2012) Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients. Intern Med 51:553\u2013557","journal-title":"Intern Med"},{"key":"2263_CR46","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3892\/etm.2012.557","volume":"4","author":"S Uslu","year":"2012","unstructured":"Uslu S, Kebapci N, Kara M et al (2012) Relationship between adipocytokines and cardiovascular risk factors in patients with type 2 diabetes mellitus. Exp Ther Med 4:113\u2013120","journal-title":"Exp Ther Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-014-2263-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-014-2263-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-014-2263-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T07:37:24Z","timestamp":1566027444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-014-2263-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,8]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["2263"],"URL":"https:\/\/doi.org\/10.1007\/s11010-014-2263-4","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,8]]}}}